Earth City, MO – February 24, 2022 – Optime Care, a nationally recognized specialty pharmacy, distribution and patient management organization maximizing therapeutic opportunities for the treatment of orphan and rare disorders, is pleased to recognize Feb. 28 as Rare Disease Day and help raise awareness of the 7,000+ rare diseases that impact over 300 million people globally. Optime Care’s patient-first approach supports family caregivers and patients through counseling, guidance and education based upon patient and caregiver needs, optimizing the therapeutic value of a specialty drug by ensuring prescription accuracy, compliance, adherence to treatment and side effects management.
“Optime Care provides continuity of care through interventions delivered at key points in the patient journey to avoid lapses in therapy and improve quality of life for these patients,” says Michelle Hefley, co-founder, managing partner and chairman, Optime Care.
“Our approach also provides exceptional support to caregivers, healthcare providers and biopharma partners, with our experienced team of specialty Rx pharmacists available 24/7 to play a critical role in helping to manage the clinical and non-clinical issues associated with rare diseases. We also help mitigate the high costs of specialty drugs, including gene/cell therapies, with custom copay assistance programs.”
As diagnosis rates for rare disease rise, the drug pipeline continues to grow and advance through clinical trials. Optime Care’s timely solution goes beyond the traditional approach to address the high costs for every stakeholder.
“At Optime Care we have patients, not quotas,” adds Hefley. “Our team members interact with patients in a compassionate way and provide better services and support for people who have been marginalized by the system or isolated by their disease state.”
Optime Care, Inc. is a nationally recognized specialty pharmacy, distribution and patient management organization offering a suite of comprehensive services tailored to maximize the therapeutic opportunities for the treatment of orphan and rare disorders.
Our executive team has partnered in the launch and management of over 40 orphan products and programs while consistently implementing the best brand services for the community. Our experience with small patient populations, coupled with our strategic partnership with AscellaHealth, enhances our services and ability to serve the specialty pharmacy market.
Optime Care has dual-accreditation from the Utilization Review Accreditation Commission (URAC) for compliance with specialty pharmacy and the Accreditation Commission for Health Care (ACHC) for specialty pharmacy services that demonstrate a commitment to providing quality care and services to consumers.